The National Institute of Allergy and Infectious Diseases (NIAID) is offering a grant to support research in developing a universal influenza vaccine, focusing on improving understanding of flu transmission, characterizing immunity, and designing effective vaccines. This grant aims to provide durable protection against various influenza strains. The R21 grant mechanism is used, suitable for high risk/high payoff projects without preliminary data. Applicants with preliminary data or planning longer-term studies may consider applying through the R01 mechanism. The closing date for applications is September 07, 2021.
Opportunity ID: 307235
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-18-858 |
| Funding Opportunity Title: | Advancing Research Needed to Develop a Universal Influenza Vaccine (R21 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 18, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 07, 2021 |
| Current Closing Date for Applications: | Sep 07, 2021 |
| Archive Date: | Oct 13, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) For profit organizations other than small businesses State governments Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Special district governments Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement is to support research activities that will advance NIAIDs mission to develop a universal influenza vaccine providing durable protection against multiple influenza strains, including efforts to: 1) improve understanding of transmission, natural history and pathogenesis of influenza virus infection; 2) characterize influenza immunity and correlates of immune protection; and 3) support rational design of universal influenza vaccines. This FOA uses the R21 grant mechanism, while the companion FOA, PA-XX-xxx , uses the R01 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism. Applicants with preliminary data and/or planning longer-term studies may wish to apply using the R01 mechanism. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-18-858.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00244663 | Sep 16, 2018 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259952 | Sep 16, 2018 | Sep 07, 2021 | View |
Package 1
Mandatory forms
307235 RR_SF424_2_0-2.0.pdf
307235 PHS398_CoverPageSupplement_4_0-4.0.pdf
307235 RR_OtherProjectInfo_1_4-1.4.pdf
307235 PerformanceSite_2_0-2.0.pdf
307235 RR_KeyPersonExpanded_2_0-2.0.pdf
307235 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
307235 RR_Budget_1_4-1.4.pdf
307235 RR_SubawardBudget30_1_4-1.4.pdf
307235 PHS398_ModularBudget_1_2-1.2.pdf
307235 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
307235 RR_SF424_2_0-2.0.pdf
307235 PHS398_CoverPageSupplement_5_0-5.0.pdf
307235 RR_OtherProjectInfo_1_4-1.4.pdf
307235 PerformanceSite_2_0-2.0.pdf
307235 RR_KeyPersonExpanded_2_0-2.0.pdf
307235 PHS398_ResearchPlan_4_0-4.0.pdf
307235 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
307235 RR_Budget_1_4-1.4.pdf
307235 RR_SubawardBudget30_1_4-1.4.pdf
307235 PHS398_ModularBudget_1_2-1.2.pdf
307235 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
